PMID: 8447934Feb 1, 1993Paper

The mechanisms of action of cyclosporin A in the treatment of psoriasis

Immunology Today
R L WongK D Cooper

Abstract

This article describes the effects of cyclosporin A (CsA) on the immunopathological mechanisms operative in psoriasis, a human skin disease. The main focus is the effect of CsA on keratinocytes, T cells and antigen-presenting cells, the key players in lesional psoriatic skin. The effect of CsA on other cells, such as neutrophils and endothelial cells, which are important in the maintenance of psoriasis, are also discussed.

References

Apr 1, 1992·Immunology Today·S L Schreiber, G R Crabtree
Aug 1, 1992·The Journal of Clinical Investigation·C HammerbergK D Cooper
May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·A Borst, M Egelhaaf
Feb 28, 1991·Nature·L J PickerE C Butcher
Feb 1, 1991·The British Journal of Dermatology·R W GrovesD M MacDonald
Jan 31, 1991·The New England Journal of Medicine·C N EllisT G Parish
Feb 1, 1990·The Journal of Experimental Medicine·A Granelli-Piperno
Sep 1, 1988·The Journal of Experimental Medicine·A B GottliebD M Carter
Oct 1, 1988·The Journal of Experimental Medicine·G E HancockZ A Cohn
Jan 1, 1989·Archives of Dermatological Research·J K LivdenR Matre
Dec 21, 1989·The New England Journal of Medicine·B D Kahan
Aug 1, 1989·European Journal of Pediatrics·R J GemkeA J Veerman
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·S M WahlM B Sporn
Apr 1, 1987·The British Journal of Dermatology·B S BakerL Fry
Jan 1, 1985·Archives of Dermatological Research·C Schubert, E Christophers
Sep 1, 1984·British Journal of Pharmacology·S D BrainA K Black

❮ Previous
Next ❯

Citations

Jul 5, 1993·Experientia·H BangU Feige
Jul 1, 1993·Immunology Today·B F Erlanger
Dec 1, 1994·Journal of the American Academy of Dermatology·J O Funk, H I Maibach
May 20, 1998·Dermatologic Clinics·J P Dutz, V C Ho
Oct 6, 1997·Clinics in Dermatology·M A de Rie, J D Bos
May 30, 2001·Journal of Dermatological Science·Y UmezawaM Koga
Jul 21, 2001·International Journal of Antimicrobial Agents·A Szkaradkiewicz, M Wal
May 13, 1999·International Journal of Dermatology·C Bonifati, F Ameglio
Mar 2, 1995·The New England Journal of Medicine·M W Greaves, G D Weinstein
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·J C ChangD J Carlo
Jan 2, 2001·Mediators of Inflammation·J E GarciaJ L Arellano
Jan 7, 2003·Viral Immunology·Steven KrakowkaGordon Allan
Apr 1, 1997·The British Journal of Dermatology·M BarnaF G Snijdewint
Jul 7, 1995·Annals of the New York Academy of Sciences·J C ChangD J Carlo
Mar 1, 2005·Journal of Periodontology·Omer Engin BulutSevda Müftüoğlu
Jun 23, 2009·Drugs·Anna L ChienCharles N Ellis
Dec 18, 2001·Journal of Pharmaceutical Sciences·K D Peteherych, K M Wasan
Jul 24, 2004·The British Journal of Dermatology·T KormeiliP S Yamauchi
Jul 11, 2007·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Alexander NastUNKNOWN Berufsverband Deutscher Dermatologen (BVDD)
Apr 12, 2012·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Alexander NastUNKNOWN Berufsverband Deutscher Dermatologen (BVDD)
Dec 1, 1995·Journal of the American Academy of Dermatology·E P PrensR Benner
Mar 12, 2002·The Journal of Investigative Dermatology·W J LinB Tomkinson
Feb 27, 2003·Veterinary Dermatology·David C Robson, Gregory G Burton
Dec 26, 2006·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Alexander NastUNKNOWN Germany Society for Dermatology
Aug 29, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·D PathiranaB Rzany
Oct 25, 2007·Expert Opinion on Pharmacotherapy·Sharon E Jacob, Mari Paz Castanedo-Tardan
Oct 17, 2006·Expert Opinion on Investigational Drugs·James VaraniHarrihar A Pershadsingh
Apr 2, 2003·Expert Opinion on Therapeutic Targets·Benjamin E Rich
Jan 1, 1997·Dermatologic Clinics·C Guzzo
Nov 1, 1996·Journal of the American Academy of Dermatology·A HannukselaJ Karvonen
Apr 19, 2005·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Mathias BayerDiamant Thaçi
Jan 30, 2019·Dermatologic Therapy·Griffin R LeeVivian Y Shi
Sep 24, 2005·Journal of Mass Spectrometry : JMS·Petr FrycákKarel Lemr
Aug 15, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·J K Griffiths
Feb 1, 1997·Therapeutic Drug Monitoring·S B CharnickJ Meligeni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.